Assessment of influenza virus exposure and recovery from contaminated surgical masks and N95 respirators.
Identifieur interne : 000276 ( PubMed/Curation ); précédent : 000275; suivant : 000277Assessment of influenza virus exposure and recovery from contaminated surgical masks and N95 respirators.
Auteurs : Francoise M. Blachere [États-Unis] ; William G. Lindsley [États-Unis] ; Cynthia M. Mcmillen [États-Unis] ; Donald H. Beezhold [États-Unis] ; Edward M. Fisher [États-Unis] ; Ronald E. Shaffer [États-Unis] ; John D. Noti [États-Unis]Source :
- Journal of virological methods [ 1879-0984 ] ; 2018.
Descripteurs français
- KwdFr :
- ARN viral (), ARN viral (génétique), Animaux, Aérosols, Cellules rénales canines Madin-Darby, Chiens, Dodécyl-sulfate de sodium (pharmacologie), Exposition professionnelle, Grippe humaine (), Grippe humaine (transmission), Humains, Masques (virologie), Personnel de santé, Respirateurs purificateurs d'air (virologie), Sérumalbumine bovine (pharmacologie), Taille de particule, Tensioactifs (pharmacologie), Virus de la grippe A (), Virus de la grippe A (génétique).
- MESH :
- génétique : ARN viral, Virus de la grippe A.
- pharmacologie : Dodécyl-sulfate de sodium, Sérumalbumine bovine, Tensioactifs.
- virologie : Masques, Respirateurs purificateurs d'air.
- ARN viral, Animaux, Aérosols, Cellules rénales canines Madin-Darby, Chiens, Exposition professionnelle, Grippe humaine, Humains, Personnel de santé, Taille de particule, Virus de la grippe A.
English descriptors
- KwdEn :
- Aerosols, Animals, Dogs, Health Personnel, Humans, Influenza A virus (drug effects), Influenza A virus (genetics), Influenza, Human (prevention & control), Influenza, Human (transmission), Madin Darby Canine Kidney Cells, Masks (virology), Occupational Exposure, Particle Size, RNA, Viral (drug effects), RNA, Viral (genetics), Respiratory Protective Devices (virology), Serum Albumin, Bovine (pharmacology), Sodium Dodecyl Sulfate (pharmacology), Surface-Active Agents (pharmacology).
- MESH :
- chemical , drug effects : RNA, Viral.
- chemical , genetics : RNA, Viral.
- chemical , pharmacology : Serum Albumin, Bovine, Sodium Dodecyl Sulfate, Surface-Active Agents.
- chemical : Aerosols.
- drug effects : Influenza A virus.
- genetics : Influenza A virus.
- prevention & control : Influenza, Human.
- transmission : Influenza, Human.
- virology : Masks, Respiratory Protective Devices.
- Animals, Dogs, Health Personnel, Humans, Madin Darby Canine Kidney Cells, Occupational Exposure, Particle Size.
Abstract
Healthcare workers (HCWs) are at significantly higher risk of exposure to influenza virus during seasonal epidemics and global pandemics. During the 2009 influenza pandemic, some healthcare organizations recommended that HCWs wear respiratory protection such as filtering facepiece respirators, while others indicated that facemasks such as surgical masks (SMs) were sufficient. To assess the level of exposure a HCW may possibly encounter, the aim of this study was to (1.) evaluate if SMs and N95 respirators can serve as "personal bioaerosol samplers" for influenza virus and (2.) determine if SMs and N95 respirators contaminated by influenza laden aerosols can serve as a source of infectious virus for indirect contact transmission. This effort is part of a National Institute for Occupational Safety and Health 5-year multidisciplinary study to determine the routes of influenza transmission in healthcare settings. A coughing simulator was programmed to cough aerosol particles containing influenza virus over a wide concentration range into an aerosol exposure simulation chamber virus/L of exam room air), and a breathing simulator was used to collect virus on either a SM or N95 respirator. Extraction buffers containing nonionic and anionic detergents as well as various protein additives were used to recover influenza virus from the masks and respirators. The inclusion of 0.1% SDS resulted in maximal influenza RNA recovery (41.3%) but with a complete loss of infectivity whereas inclusion of 0.1% bovine serum albumin resulted in reduced RNA recovery (6.8%) but maximal retention of virus infectivity (17.9%). Our results show that a HCW's potential exposure to airborne influenza virus can be assessed in part through analysis of their SMs and N95 respirators, which can effectively serve as personal bioaerosol samplers.
DOI: 10.1016/j.jviromet.2018.05.009
PubMed: 30029810
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000276
Links to Exploration step
pubmed:30029810Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Assessment of influenza virus exposure and recovery from contaminated surgical masks and N95 respirators.</title><author><name sortKey="Blachere, Francoise M" sort="Blachere, Francoise M" uniqKey="Blachere F" first="Francoise M" last="Blachere">Francoise M. Blachere</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA. Electronic address: fblachere@cdc.gov.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV</wicri:regionArea></affiliation></author><author><name sortKey="Lindsley, William G" sort="Lindsley, William G" uniqKey="Lindsley W" first="William G" last="Lindsley">William G. Lindsley</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV</wicri:regionArea></affiliation></author><author><name sortKey="Mcmillen, Cynthia M" sort="Mcmillen, Cynthia M" uniqKey="Mcmillen C" first="Cynthia M" last="Mcmillen">Cynthia M. Mcmillen</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA; Center for Vaccine Research, Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA; Center for Vaccine Research, Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA</wicri:regionArea></affiliation></author><author><name sortKey="Beezhold, Donald H" sort="Beezhold, Donald H" uniqKey="Beezhold D" first="Donald H" last="Beezhold">Donald H. Beezhold</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV</wicri:regionArea></affiliation></author><author><name sortKey="Fisher, Edward M" sort="Fisher, Edward M" uniqKey="Fisher E" first="Edward M" last="Fisher">Edward M. Fisher</name><affiliation wicri:level="1"><nlm:affiliation>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA</wicri:regionArea></affiliation></author><author><name sortKey="Shaffer, Ronald E" sort="Shaffer, Ronald E" uniqKey="Shaffer R" first="Ronald E" last="Shaffer">Ronald E. Shaffer</name><affiliation wicri:level="1"><nlm:affiliation>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA</wicri:regionArea></affiliation></author><author><name sortKey="Noti, John D" sort="Noti, John D" uniqKey="Noti J" first="John D" last="Noti">John D. Noti</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2018">2018</date><idno type="RBID">pubmed:30029810</idno><idno type="pmid">30029810</idno><idno type="doi">10.1016/j.jviromet.2018.05.009</idno><idno type="wicri:Area/PubMed/Corpus">000276</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000276</idno><idno type="wicri:Area/PubMed/Curation">000276</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000276</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Assessment of influenza virus exposure and recovery from contaminated surgical masks and N95 respirators.</title><author><name sortKey="Blachere, Francoise M" sort="Blachere, Francoise M" uniqKey="Blachere F" first="Francoise M" last="Blachere">Francoise M. Blachere</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA. Electronic address: fblachere@cdc.gov.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV</wicri:regionArea></affiliation></author><author><name sortKey="Lindsley, William G" sort="Lindsley, William G" uniqKey="Lindsley W" first="William G" last="Lindsley">William G. Lindsley</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV</wicri:regionArea></affiliation></author><author><name sortKey="Mcmillen, Cynthia M" sort="Mcmillen, Cynthia M" uniqKey="Mcmillen C" first="Cynthia M" last="Mcmillen">Cynthia M. Mcmillen</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA; Center for Vaccine Research, Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA; Center for Vaccine Research, Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA</wicri:regionArea></affiliation></author><author><name sortKey="Beezhold, Donald H" sort="Beezhold, Donald H" uniqKey="Beezhold D" first="Donald H" last="Beezhold">Donald H. Beezhold</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV</wicri:regionArea></affiliation></author><author><name sortKey="Fisher, Edward M" sort="Fisher, Edward M" uniqKey="Fisher E" first="Edward M" last="Fisher">Edward M. Fisher</name><affiliation wicri:level="1"><nlm:affiliation>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA</wicri:regionArea></affiliation></author><author><name sortKey="Shaffer, Ronald E" sort="Shaffer, Ronald E" uniqKey="Shaffer R" first="Ronald E" last="Shaffer">Ronald E. Shaffer</name><affiliation wicri:level="1"><nlm:affiliation>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA</wicri:regionArea></affiliation></author><author><name sortKey="Noti, John D" sort="Noti, John D" uniqKey="Noti J" first="John D" last="Noti">John D. Noti</name><affiliation wicri:level="1"><nlm:affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV</wicri:regionArea></affiliation></author></analytic><series><title level="j">Journal of virological methods</title><idno type="eISSN">1879-0984</idno><imprint><date when="2018" type="published">2018</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aerosols</term><term>Animals</term><term>Dogs</term><term>Health Personnel</term><term>Humans</term><term>Influenza A virus (drug effects)</term><term>Influenza A virus (genetics)</term><term>Influenza, Human (prevention & control)</term><term>Influenza, Human (transmission)</term><term>Madin Darby Canine Kidney Cells</term><term>Masks (virology)</term><term>Occupational Exposure</term><term>Particle Size</term><term>RNA, Viral (drug effects)</term><term>RNA, Viral (genetics)</term><term>Respiratory Protective Devices (virology)</term><term>Serum Albumin, Bovine (pharmacology)</term><term>Sodium Dodecyl Sulfate (pharmacology)</term><term>Surface-Active Agents (pharmacology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>ARN viral ()</term><term>ARN viral (génétique)</term><term>Animaux</term><term>Aérosols</term><term>Cellules rénales canines Madin-Darby</term><term>Chiens</term><term>Dodécyl-sulfate de sodium (pharmacologie)</term><term>Exposition professionnelle</term><term>Grippe humaine ()</term><term>Grippe humaine (transmission)</term><term>Humains</term><term>Masques (virologie)</term><term>Personnel de santé</term><term>Respirateurs purificateurs d'air (virologie)</term><term>Sérumalbumine bovine (pharmacologie)</term><term>Taille de particule</term><term>Tensioactifs (pharmacologie)</term><term>Virus de la grippe A ()</term><term>Virus de la grippe A (génétique)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>RNA, Viral</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Serum Albumin, Bovine</term><term>Sodium Dodecyl Sulfate</term><term>Surface-Active Agents</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Aerosols</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Influenza A virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>ARN viral</term><term>Virus de la grippe A</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Dodécyl-sulfate de sodium</term><term>Sérumalbumine bovine</term><term>Tensioactifs</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Masques</term><term>Respirateurs purificateurs d'air</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Masks</term><term>Respiratory Protective Devices</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Dogs</term><term>Health Personnel</term><term>Humans</term><term>Madin Darby Canine Kidney Cells</term><term>Occupational Exposure</term><term>Particle Size</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>ARN viral</term><term>Animaux</term><term>Aérosols</term><term>Cellules rénales canines Madin-Darby</term><term>Chiens</term><term>Exposition professionnelle</term><term>Grippe humaine</term><term>Humains</term><term>Personnel de santé</term><term>Taille de particule</term><term>Virus de la grippe A</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Healthcare workers (HCWs) are at significantly higher risk of exposure to influenza virus during seasonal epidemics and global pandemics. During the 2009 influenza pandemic, some healthcare organizations recommended that HCWs wear respiratory protection such as filtering facepiece respirators, while others indicated that facemasks such as surgical masks (SMs) were sufficient. To assess the level of exposure a HCW may possibly encounter, the aim of this study was to (1.) evaluate if SMs and N95 respirators can serve as "personal bioaerosol samplers" for influenza virus and (2.) determine if SMs and N95 respirators contaminated by influenza laden aerosols can serve as a source of infectious virus for indirect contact transmission. This effort is part of a National Institute for Occupational Safety and Health 5-year multidisciplinary study to determine the routes of influenza transmission in healthcare settings. A coughing simulator was programmed to cough aerosol particles containing influenza virus over a wide concentration range into an aerosol exposure simulation chamber virus/L of exam room air), and a breathing simulator was used to collect virus on either a SM or N95 respirator. Extraction buffers containing nonionic and anionic detergents as well as various protein additives were used to recover influenza virus from the masks and respirators. The inclusion of 0.1% SDS resulted in maximal influenza RNA recovery (41.3%) but with a complete loss of infectivity whereas inclusion of 0.1% bovine serum albumin resulted in reduced RNA recovery (6.8%) but maximal retention of virus infectivity (17.9%). Our results show that a HCW's potential exposure to airborne influenza virus can be assessed in part through analysis of their SMs and N95 respirators, which can effectively serve as personal bioaerosol samplers.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30029810</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-0984</ISSN><JournalIssue CitedMedium="Internet"><Volume>260</Volume><PubDate><Year>2018</Year><Month>10</Month></PubDate></JournalIssue><Title>Journal of virological methods</Title><ISOAbbreviation>J. Virol. Methods</ISOAbbreviation></Journal><ArticleTitle>Assessment of influenza virus exposure and recovery from contaminated surgical masks and N95 respirators.</ArticleTitle><Pagination><MedlinePgn>98-106</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0166-0934(18)30049-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jviromet.2018.05.009</ELocationID><Abstract><AbstractText>Healthcare workers (HCWs) are at significantly higher risk of exposure to influenza virus during seasonal epidemics and global pandemics. During the 2009 influenza pandemic, some healthcare organizations recommended that HCWs wear respiratory protection such as filtering facepiece respirators, while others indicated that facemasks such as surgical masks (SMs) were sufficient. To assess the level of exposure a HCW may possibly encounter, the aim of this study was to (1.) evaluate if SMs and N95 respirators can serve as "personal bioaerosol samplers" for influenza virus and (2.) determine if SMs and N95 respirators contaminated by influenza laden aerosols can serve as a source of infectious virus for indirect contact transmission. This effort is part of a National Institute for Occupational Safety and Health 5-year multidisciplinary study to determine the routes of influenza transmission in healthcare settings. A coughing simulator was programmed to cough aerosol particles containing influenza virus over a wide concentration range into an aerosol exposure simulation chamber virus/L of exam room air), and a breathing simulator was used to collect virus on either a SM or N95 respirator. Extraction buffers containing nonionic and anionic detergents as well as various protein additives were used to recover influenza virus from the masks and respirators. The inclusion of 0.1% SDS resulted in maximal influenza RNA recovery (41.3%) but with a complete loss of infectivity whereas inclusion of 0.1% bovine serum albumin resulted in reduced RNA recovery (6.8%) but maximal retention of virus infectivity (17.9%). Our results show that a HCW's potential exposure to airborne influenza virus can be assessed in part through analysis of their SMs and N95 respirators, which can effectively serve as personal bioaerosol samplers.</AbstractText><CopyrightInformation>Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blachere</LastName><ForeName>Francoise M</ForeName><Initials>FM</Initials><AffiliationInfo><Affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA. Electronic address: fblachere@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindsley</LastName><ForeName>William G</ForeName><Initials>WG</Initials><AffiliationInfo><Affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McMillen</LastName><ForeName>Cynthia M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA; Center for Vaccine Research, Infectious Diseases and Microbiology, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beezhold</LastName><ForeName>Donald H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Edward M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaffer</LastName><ForeName>Ronald E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>National Personal Protective Technology Laboratory, National Institute for Occupational Safety and Health, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noti</LastName><ForeName>John D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, WV, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CC999999</GrantID><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Virol Methods</MedlineTA><NlmUniqueID>8005839</NlmUniqueID><ISSNLinking>0166-0934</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000336">Aerosols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013501">Surface-Active Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>27432CM55Q</RegistryNumber><NameOfSubstance UI="D012710">Serum Albumin, Bovine</NameOfSubstance></Chemical><Chemical><RegistryNumber>368GB5141J</RegistryNumber><NameOfSubstance UI="D012967">Sodium Dodecyl Sulfate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000336" MajorTopicYN="N">Aerosols</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="Y">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009980" MajorTopicYN="N">Influenza A virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061985" MajorTopicYN="N">Madin Darby Canine Kidney Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008397" MajorTopicYN="N">Masks</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016273" MajorTopicYN="Y">Occupational Exposure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010316" MajorTopicYN="N">Particle Size</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012134" MajorTopicYN="N">Respiratory Protective Devices</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012710" MajorTopicYN="N">Serum Albumin, Bovine</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012967" MajorTopicYN="N">Sodium Dodecyl Sulfate</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013501" MajorTopicYN="N">Surface-Active Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Aerosol transmission</Keyword><Keyword MajorTopicYN="Y">Healthcare worker</Keyword><Keyword MajorTopicYN="Y">Influenza A</Keyword><Keyword MajorTopicYN="Y">PPE contamination</Keyword><Keyword MajorTopicYN="Y">Quantitative PCR</Keyword><Keyword MajorTopicYN="Y">Virus extraction</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>01</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>04</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>05</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>7</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30029810</ArticleId><ArticleId IdType="pii">S0166-0934(18)30049-1</ArticleId><ArticleId IdType="doi">10.1016/j.jviromet.2018.05.009</ArticleId><ArticleId IdType="pmc">PMC6482848</ArticleId><ArticleId IdType="mid">NIHMS1013533</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000276 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000276 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:30029810
|texte= Assessment of influenza virus exposure and recovery from contaminated surgical masks and N95 respirators.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:30029810" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |